(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 1158.57 | 1250.24 | -7.33 | 1158.57 | 1250.24 | -7.33 | 4527.66 | 3514.11 | 28.84 |
| Other Income | 22.87 | 538.52 | -95.75 | 22.87 | 538.52 | -95.75 | 633.88 | 614.90 | 3.09 |
| PBIDT | 326.99 | 843.78 | -61.25 | 326.99 | 843.78 | -61.25 | 1738.22 | 1321.69 | 31.51 |
| Interest | 0.37 | 0.53 | -30.19 | 0.37 | 0.53 | -30.19 | 2.07 | 2.36 | -12.29 |
| PBDT | 326.62 | 843.25 | -61.27 | 326.62 | 843.25 | -61.27 | 1697.57 | 1319.33 | 28.67 |
| Depreciation | 29.21 | 29.29 | -0.27 | 29.21 | 29.29 | -0.27 | 120.83 | 114.05 | 5.94 |
| PBT | 297.41 | 813.96 | -63.46 | 297.41 | 813.96 | -63.46 | 1576.74 | 1205.28 | 30.82 |
| TAX | 73.95 | 74.15 | -0.27 | 73.95 | 74.15 | -0.27 | 258.68 | 181.08 | 42.85 |
| Deferred Tax | 7.31 | -0.26 | -2911.54 | 7.31 | -0.26 | -2911.54 | -12.01 | 12.22 | -198.28 |
| PAT | 223.46 | 739.81 | -69.79 | 223.46 | 739.81 | -69.79 | 1318.06 | 1024.20 | 28.69 |
| Equity | 223.95 | 223.76 | 0.08 | 223.95 | 223.76 | 0.08 | 223.85 | 223.76 | 0.04 |
| PBIDTM(%) | 28.22 | 67.49 | -58.18 | 28.22 | 67.49 | -58.18 | 38.39 | 37.61 | 2.07 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1892.05 |
| Dr. Reddys Labs. | 1180.60 |
| Cipla | 1425.15 |
| Lupin | 2215.80 |
| Zydus Lifesciences | 1114.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: